Beta adrenergic blockers in chronic congestive cardiac failure: A call for action

European Journal of Internal Medicine

Volumn 13, Issue 2, 2002, Pages 96-100

  Mahon, Niall G ^a   Young, James B ^b   McKenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Beta adrenergic receptor antagonist; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; PROSTACYCLIN; VALSARTAN;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG MECHANISM; DRUG USE; EXPERIENCE; HUMAN; NEUROENDOCRINE SYSTEM; REVIEW;

EID: 0036120781     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00010-9     Document Type: Review

References (27)

1. The adrenergic nervous system in the control of the normal and failing heart
2. Beta-adrenergic receptor blockade in chronic heart failure
3. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
4. Use of propranolol in thyrotoxicosis
5. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
6. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
7. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
8. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
9. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
10. Effect of carvedilol on survival in severe chronic heart failure
11. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
12. Heart Failure 99 - The MOXCON story
13. Expanding indications for beta-blockers in heart failure
14. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme inhibitors (SPICE) registry
15. Baseline demographics of the Valsartan heart failure trial
16. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized medicare patients in ten large states
17. Patterns of medication use in patients with heart failure: A report from the Registry of Studies of Left Ventricular Dysfunction (SOLVD)
18. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
19. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
20. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: Results of a meta-analysis
21. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation
22. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure
23. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
24. Heart rate is a marker of amiodarone mortality reduction in severe heart failure
25. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial
26. Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms: Analysis of c145A>G and c1165G>C
27. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure